DaShenLin Pharmaceutical Group Co Stock

DaShenLin Pharmaceutical Group Co Forward P/E

The Forward P/E Ratio of DaShenLin Pharmaceutical Group Co (603233.SS) as of Aug 16, 2026 is 23.87. In the previous year, Forward P/E Ratio was 18.72 — a change of 27.52% (higher).

Forward P/E

23.87

YoY

27.52%

Last updated:

Forward P/E Ratio of DaShenLin Pharmaceutical Group Co is 2026 23.87 . Forward P/E Ratio of DaShenLin Pharmaceutical Group Co was 2025 18.72 . It decreases by 27.52% higher compared to the previous year.
Access this data via the Eulerpool API

DaShenLin Pharmaceutical Group Co Stock analysis

What does DaShenLin Pharmaceutical Group Co do? DaShenLin Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DaShenLin Pharmaceutical Group Co stock

Forward P/E Ratio of DaShenLin Pharmaceutical Group Co is 23.87 in 2026.

Forward P/E Ratio of DaShenLin Pharmaceutical Group Co changed from 18.72 to 23.87, representing a 27.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio DaShenLin Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's DaShenLin Pharmaceutical Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — DaShenLin Pharmaceutical Group Co

All Key Metrics — DaShenLin Pharmaceutical Group Co